<DOC>
	<DOCNO>NCT02733783</DOCNO>
	<brief_summary>The primary aim study create model ; order examine effect neural trauma patient healthy individual , induce control nasal fracture rhinoplasty , regeneration process weeks/months follow . This study include monitor subjective nasal symptom visual analogue scale ( VAS ) score , peak nasal inspiratory flow ( PNIF ) measurement , collection nasal secretion nasal provocation ( response capsaicin cold dry air ( CDA ) exposure ) .</brief_summary>
	<brief_title>Design Model Study Functionality Trigeminal Nerve Relation Controlled Nasal Fractures</brief_title>
	<detailed_description>The investigator set prospective mono-center study . The investigator utilize objective subjective parameter order ass trigeminal nerve function level nasal mucosa septorhinoplasty ( model control nasal fracture ) . The subjective parameter involve visual analogue scale ( VAS ) score individual nasal symptom ( nasal obstruction , facial pain/pressure , headache , rhinorrhea , sneeze , pruritus , post nasal drip , loss smell ) . An objective assessment include measurement PNIF ( Peak Nasal Inspiratory Flow ) , presence neuropeptides nasal secretion , ( introduce merocels remove 5 minute later ) , short cold dry air ( CDA ) provocation capsaicin provocation subsequent measurement PNIF VAS score neuropeptides .</detailed_description>
	<mesh_term>Fractures , Bone</mesh_term>
	<criteria>1 . Patients undergo septorhinoplasty , planned bilateral osteotomy 2 . No rhinological symptoms/complaints ( rhinorrhea , sneeze , itchiness , nasal obstruction ) 3 . Age &gt; 18 &lt; 65 year 4 . Written inform consent 5 . Willingness adhere visit schedule 6 . Adequate contraceptive precaution female patient childbearing potential 1 . Age &lt; 18 &gt; 65 year 2 . Patients nasal symptom baseline , define 2,5 VAS score individual nasal symptom relate mucosal pathology 3 . Nasal endoscopic sign inflammatory pathology ( rhinitis , rhinosinusitis with/without nasal polyp ) 4 . Use systemic steroid treatment , intranasal steroid treatment , oral leukotriene antagonist long act antihistamine ? 5 . Asthma 6 . Pregnancy breastfeed 7 . Any disorder might compromise ability patient give truly informed consent participation study . 8 . Enrollment investigational drug trial ( ) receive investigational agent ( ) medical condition . 9 . Contraindications local anaesthesia ( Cocaine 5 % ) 10 . Smoking 11 . Systemic disease lesion ENT domain 12 . Malignancies severe comorbidity</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>65 Years</maximum_age>
	<verification_date>April 2016</verification_date>
</DOC>